BioGraphene Presented at the Annual Ara Parseghian Medical Research Conference

BioGraphene Inc. was greatly honored to receive an invitation to attend and present at the Annual Ara Parseghian Medical Research Conference (May 22~24, Tucson/USA) which highlights advancements in potential therapies and treatments for Niemann-Pick Disease Type C.

By highlighting how it plans to use its graphene quantum dots to assist in the effective clearance of trapped cholesterol, BioGraphene looked to collaborate with this amazing community and work towards meaningful outcomes for the patients.

Jake Hostetler, Head of Business Development, made an oral presentation about “Graphene Quantum Dots as a Therapeutic Candidate in Niemann-Pick Disease Type C”.